デフォルト表紙
市場調査レポート
商品コード
1769755

睡眠丸薬の世界市場レポート2025年

Sleeping Pills Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
睡眠丸薬の世界市場レポート2025年
出版日: 2025年07月07日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

睡眠丸薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率(CAGR)8.1%で1,173億1,000万米ドルに成長します。この成長予測は、非中毒性ソリューションへの嗜好の高まり、個別化・標的化睡眠療法の革新、バイオテクノロジーへの投資の強化、規制経路の厳格化、ヘルスケアシステムの拡大によってもたらされます。予測期間中に予想される主な動向には、カスタマイズされた睡眠治療のためのデジタルバイオマーカーの利用、AIと機械学習の応用、カンナビノイドベースの治療の進歩、ナノテクを利用したドラッグデリバリー、睡眠追跡のためのウェアラブルデバイスなどがあります。

精神疾患の有病率の増加は、今後数年間の睡眠丸薬市場の拡大を促進すると予想されます。精神疾患には、気分、認知、行動、全体的な機能に影響を及ぼす幅広い疾患が含まれます。精神疾患患者の増加は、脳機能を損ない精神疾患を悪化させる可能性のある慢性的なストレスレベルの増加に大きく起因しています。睡眠丸薬は、感情や認知の安定を維持するために不可欠な睡眠の質を高めることで、メンタルヘルス問題の管理に重要な役割を果たしています。これらの薬は、安らかな睡眠を促し、メンタルヘルスと日常生活機能の改善をサポートすることで、不安や抑うつの症状を緩和するのに役立ちます。例えば、2022年、米国国立精神衛生研究所(National Institute of Mental Health)は、米国の18歳以上の成人5,930万人が何らかの精神疾患(AMI)と共に生活しており、これは成人人口の23.1%に相当すると報告しました。その結果、精神疾患の有病率の上昇は、睡眠丸薬の需要拡大の重要な原動力となっています。

睡眠丸薬市場で事業を展開する企業は、睡眠の質を改善し、依存の可能性を減らし、副作用を最小限に抑えるための新興国製剤の開発にますます力を注いでいます。このような高度な製剤は、有効性の向上、吸収性の改善、副作用の軽減、より的を絞った患者に優しい治療の提供を目的とした新しい薬剤組成物の創出を伴う。例えば、2024年10月、英国の医療機器会社ニューロバレンズは、22歳以上の成人の慢性不眠症の治療用としてFDAの認可を受けた医師処方の医療機器、モディウス・スリープを発表しました。この装置は、低レベルの電気的前庭神経刺激により、視床下部と脳幹、つまり睡眠と概日リズムを調整する重要な領域に影響を与えます。通常就寝の1~2時間前、夕方に30分間頭部に装着し、快適さを保つために強度を調節できるのが特徴で、読書やテレビ鑑賞などの余暇活動中にも使用できます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の睡眠丸薬:PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の睡眠丸薬市場:成長率分析
  • 世界の睡眠丸薬市場の実績:規模と成長, 2019-2024
  • 世界の睡眠丸薬市場の予測:規模と成長, 2024-2029, 2034F
  • 世界の睡眠丸薬:総潜在市場規模(TAM)

第6章 市場セグメンテーション

  • 世界の睡眠丸薬市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 処方箋睡眠丸薬
  • 市販薬(OTC)睡眠丸薬
  • 世界の睡眠丸薬市場:製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ベンゾジアゼピン
  • 非ベンゾジアゼピン
  • 世界の睡眠丸薬市場:睡眠障害別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 不眠症
  • 睡眠障害
  • レストレスレッグス症候群およびナルコレプシー
  • 夢遊病
  • 世界の睡眠丸薬市場:消費者層別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 年齢層
  • 性別
  • 健康状態
  • 世界の睡眠丸薬市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 小売薬局
  • オンライン薬局
  • 病院と診療所
  • 健康とウェルネスストア
  • 世界の睡眠丸薬市場、処方睡眠丸薬、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • ベンゾジアゼピン
  • 非ベンゾジアゼピン系薬剤
  • 抗うつ薬
  • 抗ヒスタミン薬
  • メラトニン受容体作動薬
  • オレキシン受容体拮抗薬
  • 世界の睡眠丸薬市場、市販薬(OTC)、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • ジフェンヒドラミン
  • ドキシラミン
  • メラトニンサプリメント
  • バレリアン根
  • スボレキサント
  • その他のハーブまたは天然サプリメント

第7章 地域別・国別分析

  • 世界の睡眠丸薬市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の睡眠丸薬市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 睡眠丸薬市場:競合情勢
  • 睡眠丸薬市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Abbott Laboratories
  • GSK plc
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Eisai Co Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Apotex Inc.
  • Cipla Limited
  • Aurobindo Pharma Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Hikma Pharmaceuticals plc
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 睡眠丸薬市場2029:新たな機会を提供する国
  • 睡眠丸薬市場2029:新たな機会を提供するセグメント
  • 睡眠丸薬市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r36072

Sleeping pills, also referred to as sedative-hypnotics, are drugs designed to aid individuals in initiating or maintaining sleep. These medications are frequently prescribed for the short-term management of insomnia or other related sleep disorders. By depressing the central nervous system, sleeping pills help induce drowsiness and encourage restful sleep.

There are two primary categories of sleeping pills: prescription and over-the-counter (OTC) options. These substances, which include a range of product types such as benzodiazepines and non-benzodiazepines, are intended to assist individuals in falling asleep, staying asleep, or enhancing overall sleep quality. They are used in the treatment of various conditions like insomnia, sleep apnea, restless leg syndrome, narcolepsy, and sleepwalking. Consumer demand for these products differs based on demographics such as age, gender, and health status. They are distributed through several channels, including retail pharmacies, online platforms, hospitals and clinics, as well as health and wellness outlets.

The sleeping pills market research report is one of a series of new reports from The Business Research Company that provides sleeping pills market statistics, including sleeping pills industry global market size, regional shares, competitors with a sleeping pills market share, sleeping pills market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping pills industry. This sleeping pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sleeping pills market size has grown strongly in recent years. It will grow from $79.21 billion in 2024 to $85.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. Growth during the historical period was supported by heightened awareness of sleep health, rising stress and anxiety levels, lifestyle shifts due to urbanization, a growing elderly population, and increased R&D efforts.

The sleeping pills market size is expected to see strong growth in the next few years. It will grow to $117.31 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. This projected growth is driven by the rising preference for non-addictive solutions, innovations in personalized and targeted sleep therapies, enhanced investments in biotechnology, stricter regulatory pathways, and the expansion of healthcare systems. Key trends anticipated during the forecast period include the use of digital biomarkers for customized sleep treatments, AI and machine learning applications, progress in cannabinoid-based therapies, nanotech-enabled drug delivery, and wearable devices for sleep tracking.

The growing prevalence of mental illness is anticipated to drive the expansion of the sleeping pills market in the coming years. Mental illness encompasses a broad range of conditions that influence mood, cognition, behavior, and overall functioning. The rise in mental illness cases is largely attributed to increasing levels of chronic stress, which can impair brain function and exacerbate mental health disorders. Sleeping pills play a significant role in managing mental health issues by enhancing sleep quality, which is vital for maintaining emotional and cognitive stability. These medications help alleviate symptoms of anxiety and depression by promoting restful sleep and supporting improved mental health and daily functioning. For example, in 2022, the National Institute of Mental Health reported that 59.3 million adults aged 18 and older in the United States were living with any mental illness (AMI), representing 23.1% of the adult population. As a result, the rising prevalence of mental illness is a key driver behind the growing demand for sleeping pills.

Companies operating in the sleeping pills market are increasingly focused on developing advanced formulations to improve sleep quality, reduce dependency potential, and minimize side effects. These advanced formulations involve creating new medication compositions aimed at enhancing effectiveness, improving absorption, reducing adverse effects, and offering more targeted, patient-friendly treatments. For example, in October 2024, UK-based medical device company Neurovalens introduced Modius Sleep, a physician-prescribed medical device cleared by the FDA for treating chronic insomnia in adults aged 22 and older. This device uses low-level electrical vestibular nerve stimulation to influence the hypothalamus and brainstem-key areas responsible for regulating sleep and circadian rhythms. Worn on the head for 30 minutes in the evening, typically 1-2 hours before bedtime, the device features adjustable intensity for comfort and can be used during leisure activities such as reading or watching television.

In October 2023, Apnimed, a pharmaceutical company based in the United States, entered a joint venture with Shionogi & Co. Ltd. to develop new pharmacologic treatments for obstructive sleep apnea and other sleep-related disorders. The collaboration focuses on innovative oral treatment solutions. Shionogi & Co. Ltd., headquartered in Japan, specializes in the development of advanced sleeping pills and oral therapies for sleep disorders.

Major players in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health.

Norh America was the largest region in the sleeping pills market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in sleeping pills report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sleeping pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sleeping pills market consists of sales of over-the-counter antihistamines, melatonin supplements, and herbal or natural sleep remedies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sleeping Pills Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sleeping pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sleeping pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sleeping pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Prescription Sleeping Pills; Over The Counter (OTC) Sleeping Pills
  • 2) By Product Type: Benzodiazepines; Non Benzodiazepines
  • 3) By Sleep Disorder: Insomnia; Sleep Disorder; Restless Leg Syndrome Narcolepsy; Sleepwalking
  • 4) By Consumer Demographics: Age Groups; Gender; Health Conditions
  • 5) By Distribution Channel: Retail Pharmacies; Online Pharmacies; Hospitals And Clinics; Health And Wellness Stores
  • Subsegments:
  • 1) By Prescription Sleeping Pills: Benzodiazepines; Non-Benzodiazepines; Antidepressants; Antihistamines; Melatonin Receptor Agonists; Orexin Receptor Antagonists
  • 2) By Over The Counter (OTC): Diphenhydramine; Doxylamine; Melatonin Supplements; Valerian Root; Other Herbal Or Natural Supplements
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sleeping Pills Market Characteristics

3. Sleeping Pills Market Trends And Strategies

4. Sleeping Pills Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sleeping Pills Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sleeping Pills PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sleeping Pills Market Growth Rate Analysis
  • 5.4. Global Sleeping Pills Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sleeping Pills Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sleeping Pills Total Addressable Market (TAM)

6. Sleeping Pills Market Segmentation

  • 6.1. Global Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription Sleeping Pills
  • Over The Counter (OTC) Sleeping Pills
  • 6.2. Global Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benzodiazepines
  • Non Benzodiazepines
  • 6.3. Global Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insomnia
  • Sleep Disorder
  • Restless Leg Syndrome Narcolepsy
  • Sleepwalking
  • 6.4. Global Sleeping Pills Market, Segmentation By Consumer Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Age Groups
  • Gender
  • Health Conditions
  • 6.5. Global Sleeping Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail Pharmacies
  • Online Pharmacies
  • Hospitals And Clinics
  • Health And Wellness Stores
  • 6.6. Global Sleeping Pills Market, Sub-Segmentation Of Prescription Sleeping Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Benzodiazepines
  • Non-Benzodiazepines
  • Antidepressants
  • Antihistamines
  • Melatonin Receptor Agonists
  • Orexin Receptor Antagonists
  • 6.7. Global Sleeping Pills Market, Sub-Segmentation Of Over The Counter (OTC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diphenhydramine
  • Doxylamine
  • Melatonin Supplements
  • Valerian Root
  • Suvorexant
  • Other Herbal Or Natural Supplements

7. Sleeping Pills Market Regional And Country Analysis

  • 7.1. Global Sleeping Pills Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sleeping Pills Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sleeping Pills Market

  • 8.1. Asia-Pacific Sleeping Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sleeping Pills Market

  • 9.1. China Sleeping Pills Market Overview
  • 9.2. China Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sleeping Pills Market

  • 10.1. India Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sleeping Pills Market

  • 11.1. Japan Sleeping Pills Market Overview
  • 11.2. Japan Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sleeping Pills Market

  • 12.1. Australia Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sleeping Pills Market

  • 13.1. Indonesia Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sleeping Pills Market

  • 14.1. South Korea Sleeping Pills Market Overview
  • 14.2. South Korea Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sleeping Pills Market

  • 15.1. Western Europe Sleeping Pills Market Overview
  • 15.2. Western Europe Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sleeping Pills Market

  • 16.1. UK Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sleeping Pills Market

  • 17.1. Germany Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sleeping Pills Market

  • 18.1. France Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sleeping Pills Market

  • 19.1. Italy Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sleeping Pills Market

  • 20.1. Spain Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sleeping Pills Market

  • 21.1. Eastern Europe Sleeping Pills Market Overview
  • 21.2. Eastern Europe Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sleeping Pills Market

  • 22.1. Russia Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sleeping Pills Market

  • 23.1. North America Sleeping Pills Market Overview
  • 23.2. North America Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sleeping Pills Market

  • 24.1. USA Sleeping Pills Market Overview
  • 24.2. USA Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sleeping Pills Market

  • 25.1. Canada Sleeping Pills Market Overview
  • 25.2. Canada Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sleeping Pills Market

  • 26.1. South America Sleeping Pills Market Overview
  • 26.2. South America Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sleeping Pills Market

  • 27.1. Brazil Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sleeping Pills Market

  • 28.1. Middle East Sleeping Pills Market Overview
  • 28.2. Middle East Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sleeping Pills Market

  • 29.1. Africa Sleeping Pills Market Overview
  • 29.2. Africa Sleeping Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sleeping Pills Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sleeping Pills Market, Segmentation By Sleep Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sleeping Pills Market Competitive Landscape And Company Profiles

  • 30.1. Sleeping Pills Market Competitive Landscape
  • 30.2. Sleeping Pills Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Sleeping Pills Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. GSK plc
  • 31.3. Takeda Pharmaceutical Company Limited
  • 31.4. Eli Lilly and Company
  • 31.5. Viatris Inc.
  • 31.6. Teva Pharmaceutical Industries Ltd.
  • 31.7. Eisai Co Ltd.
  • 31.8. Sun Pharmaceutical Industries Ltd.
  • 31.9. Apotex Inc.
  • 31.10. Cipla Limited
  • 31.11. Aurobindo Pharma Ltd.
  • 31.12. Dr. Reddy's Laboratories Ltd.
  • 31.13. Hikma Pharmaceuticals plc
  • 31.14. Lupin Limited
  • 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Sleeping Pills Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sleeping Pills Market

34. Recent Developments In The Sleeping Pills Market

35. Sleeping Pills Market High Potential Countries, Segments and Strategies

  • 35.1 Sleeping Pills Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sleeping Pills Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sleeping Pills Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer